Sign In
Buy ABT
$100.79
+0.200 (+0.199%)
At Close: Jul 23, 2026
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results
09:38am, Friday, 17'th Jul 2026
Abbott Laboratories (NYSE:ABT) reported upbeat second-quarter results and raised its full-year adjusted earnings outlook on Thursday.
Compass Pathways gains Jefferies support as COMP360 data distinguishes psychological support from psychotherapy
08:50am, Friday, 17'th Jul 2026
Compass Pathways (NASDAQ:CMPS)'s COMP360 treatment model may face fewer regulatory hurdles as new Phase II analysis distinguishes the company’s...
Abbott To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Friday
08:00am, Friday, 17'th Jul 2026
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Abbott Laboratories: Pick Up This Dividend King Deal Now
07:30am, Friday, 17'th Jul 2026
Abbott Laboratories has rallied sharply since my last "Buy" rating in May. Strength in its core Medical Devices business and the recently acquired Exact Sciences should keep driving strong growth for
Abbott Laboratories (NYSE:ABT) Shares Gap Up Following Better-Than-Expected Earnings
04:33am, Friday, 17'th Jul 2026
Abbott Laboratories (NYSE: ABT - Get Free Report) shares gapped up before the market opened on Thursday following a stronger than expected earnings report. The stock had previously closed at $89.27, b
Why Abbott Stock Jumped Today
10:20pm, Thursday, 16'th Jul 2026
Demand for Abbott's medical devices and diagnostic tests is rising. The company has increased its dividend for 54 straight years.
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
01:45pm, Thursday, 16'th Jul 2026
Abbott Laboratories NYSE: ABT gave the market what it wanted in its Q2 earnings report, affirming that the Exact Sciences acquisition was a good one. The critical takeaways are that comp growth is so
Abbott Laboratories (ABT) Q2 2026 Earnings Call Transcript
01:16pm, Thursday, 16'th Jul 2026
Abbott Laboratories (ABT) Q2 2026 Earnings Call Transcript
Dow Jones Hangs On While Memory Chips Take Another Beating
01:03pm, Thursday, 16'th Jul 2026
Why is the Dow holding up while the Nasdaq sinks? Healthcare gains are offsetting the semiconductor carnage.
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
12:51pm, Thursday, 16'th Jul 2026
ABT tops Q2 earnings and revenue estimates and lifts 2026 EPS guidance, while Medical Devices and Cancer Diagnostics fuel growth despite Nutrition weakness.
Abbott Laboratories shares jump as earnings beat estimates and company raises 2026 outlook
12:28pm, Thursday, 16'th Jul 2026
Abbott Laboratories (NYSE:ABT) shares rose nearly 11% on Thursday after the healthcare company reported second quarter 2026 results that topped Wall Street expectations and raised its full-year adjust
Nasdaq slides as chip selloff drags Wall Street lower
12:20pm, Thursday, 16'th Jul 2026
4:15pm: Semiconductor selloff Wall Street ended lower on Thursday, with semiconductor stocks leading the decline as investors took a step back from the AI...
Tech Rally Fizzles as UnitedHealth Props Up Dow
11:58am, Thursday, 16'th Jul 2026
The Dow and Russell 2000 are higher today, while the S&P 500 and Nasdaq move lower alongside chip stocks
Abbott Laboratories: Double Beat And Raise Surprises The Street (Rating Upgrade)
11:46am, Thursday, 16'th Jul 2026
Abbott Laboratories delivered strong Q2 results, beating expectations and raising FY 2026 guidance, prompting a 14% stock surge. ABT's valuation now appears fair, with normalized EPS estimated at $5.8
Abbott Laboratories Q2 Earnings Call Highlights
11:05am, Thursday, 16'th Jul 2026
Abbott Laboratories NYSE: ABT reported second-quarter 2026 comparable sales growth of 4.8% and adjusted earnings per share of $1.31, with Chairman and Chief Executive Officer Robert Ford saying result
